Hepatitis A vaccination
Hepatitis A is an important public health issue worldwide. Hepatitis A vaccine (HepA) was first licensed in 1992. Both inactivated HepA (HepA-I) and live attenuated HepA (HepA-L) are highly immunogenic and well tolerated, and immune protection postvaccination can persist for at least 20 y. HepA is e...
Saved in:
Published in | Human vaccines & immunotherapeutics Vol. 16; no. 7; pp. 1565 - 1573 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
United States
Taylor & Francis
02.07.2020
Taylor & Francis Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!